Germany · Delayed Price · Currency is EUR Scandinavian ChemoTech AB Statistics
Total Valuation
FRA:8V6 has a market cap or net worth of EUR 9.49 million. The enterprise value is 9.14 million.
| Market Cap | 9.49M |
| Enterprise Value | 9.14M |
Important Dates
The last earnings date was Tuesday, February 17, 2026.
| Earnings Date | Feb 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 23.80M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +16.32% |
| Shares Change (QoQ) | +11.69% |
| Owned by Insiders (%) | 25.46% |
| Owned by Institutions (%) | 13.24% |
| Float | 16.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.36 |
| PB Ratio | 32.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.28 |
| EV / Sales | 7.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.91
| Current Ratio | 0.91 |
| Quick Ratio | 0.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.06 |
Financial Efficiency
Return on equity (ROE) is -175.78% and return on invested capital (ROIC) is -88.14%.
| Return on Equity (ROE) | -175.78% |
| Return on Assets (ROA) | -30.39% |
| Return on Invested Capital (ROIC) | -88.14% |
| Return on Capital Employed (ROCE) | -202.86% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.14M |
| Profits Per Employee | -744,397 |
| Employee Count | 1 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 0.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +436.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +436.67% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 52.39 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:8V6 had revenue of EUR 1.14 million and -744,397 in losses. Loss per share was -0.03.
| Revenue | 1.14M |
| Gross Profit | 951,380 |
| Operating Income | -597,200 |
| Pretax Income | -744,397 |
| Net Income | -744,397 |
| EBITDA | -414,889 |
| EBIT | -597,200 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 338,934 in cash and n/a in debt, with a net cash position of 338,934.
| Cash & Cash Equivalents | 338,934 |
| Total Debt | n/a |
| Net Cash | 338,934 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 294,395 |
| Book Value Per Share | 0.01 |
| Working Capital | -80,945 |
Cash Flow
| Operating Cash Flow | -345,956 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 83.81%, with operating and profit margins of -52.61% and -65.58%.
| Gross Margin | 83.81% |
| Operating Margin | -52.61% |
| Pretax Margin | -65.58% |
| Profit Margin | -65.58% |
| EBITDA Margin | -36.55% |
| EBIT Margin | -52.61% |
| FCF Margin | n/a |
Dividends & Yields
FRA:8V6 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.32% |
| Shareholder Yield | -16.32% |
| Earnings Yield | -7.85% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |